Cartalax
- Createtime: 2026-06-12
- Updatetime: 2026-06-11
Product Details
| useage |
Research-grade cartilage regulatory peptide for chondrocyte metabolism, joint protection a
|
| deliveryInfo |
|
| appearance |
White lyophilized powder
|
| aliasen |
|
| supplyCapacity |
100G/Day
|
| harbor |
Hong Kong
|
| minorder |
1G
|
| Payment method |
Alibaba, PayPal, USDT, bank card, Western Union remittance
|
| Delivery date |
7 days
|
| Whatsapp |
86 131 7158 8872
|
Name: Cartalax
CAS Registry number: 231102-99-3
Sequence: Ala-Glu-Asp (AED)
Molecular Formula: C??H??N?O?
Molecular Weight: 333.29 Da
Purity: ≥99% (by HPLC)
Appearance: White lyophilized powder
Packing: 10 vials/box
Product Group: Peptide
Storage Conditions: Store at -20℃ in a dry, dark place; avoid repeated freeze-thaw cycles.
Brief Introduction:
Cartalax is a synthetic tripeptide bioregulator (Ala-Glu-Asp, AED) designed for research use only. It is studied for its potential effects on cartilage metabolism, chondrocyte function and connective tissue regulation.
Main Research Applications:
1. Cartilage and joint tissue research: Used in preclinical models to investigate effects on chondrocyte metabolism, extracellular matrix synthesis and cartilage repair mechanisms.
2. Connective tissue and extracellular matrix studies: Applied in research on fibroblast activity, collagen regulation and tissue remodeling processes.
3. Bioregulator and gene expression studies: Suitable for exploring peptide-mediated regulation of cartilage-related gene expression and musculoskeletal tissue physiological functions.
Note:
This product is for laboratory research use only. It is not intended for human or animal therapeutic use, clinical trials, or any form of in vivo administration without prior ethical approval and regulatory authorization.